A recent study utilizing cryo-EM advances our understanding of how bacterial immune systems function and reveals new aspects ...

Using a CRISPR-based biosensor platform, researchers have detected microRNA biomarkers of Alzheimer’s disease, with the ...

If you are wondering whether CRISPR Therapeutics at around US$48.75 is a bargain or a concern, the key question is how its current share price lines up with what the business may be worth. The stock ...

CRISPR/Cas-based biosensors offer an opportunity to quantify neuroinflammation in Parkinson’s disease, advancing diagnostics ...

Kiana Aran, Associate Professor of Bioengineering and Medicine at the University of California San Diego, spoke with Rudra Chaudhuri, Vice President of the Observer Research Foundation, at the Raisina ...

If you are wondering whether CRISPR Therapeutics at around US$53.52 is offering good value today, you are not alone. The stock often attracts investors who care about price versus potential. The share ...

The 10th Annual Smithies Symposium will take place on Thursday, March 26 from 3 to 4:30 p.m. (doors open at 2:30 p.m.) in the UNC Medical Biomolecular Research Building (MBRB), Room 2204, and is open ...

A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way ...

A silent revolution is unfolding inside Indian laboratories. From the patent-free power of an indigenous CRISPR tool to ...

These two biotechs have a lot in common. Their differences are even more pronounced.

Scientists at the Wisconsin Crop Innovation Center are pioneering the future of hemp farming. Researchers at UW-Madison have ...

Researchers at Case Western Reserve University found evidence that gut bacteria may contribute to brain damage in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Their study ...